Eiger Biopharmaceuticals obtains rights to lonafarnib for Hutchinson-Gilford progeria syndrome May 17, 2018
First phase III clinical results presented for esketamine in treatment-resistant depression May 17, 2018
FDA grants rare pediatric disease designation to MYO-101 for limb girdle muscular dystrophy type 2E May 17, 2018
RSS